Fora Capital, LLC Provention Bio, Inc. Transaction History

Fora Capital, LLC

  • $791 Million
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023
BUY
$6.7 - $24.21 $271,879 - $982,417
40,579 New
40,579 $977,000
Q1 2021

May 17, 2021
SELL
$10.12 - $19.45 $75,333 - $144,785
-7,444 Closed
0 $0
Q4 2020

Feb 12, 2021
BUY
$11.79 - $18.94 $87,764 - $140,989
7,444 New
7,444 $126,000
Q2 2020

Aug 14, 2020
SELL
$7.81 - $17.0 $27,046 - $58,871
-3,463 Closed
0 $0
Q1 2020

May 15, 2020
BUY
$5.42 - $17.75 $18,769 - $61,468
3,463 New
3,463 $31,000

Others Institutions Holding PRVB

# of Institutions
1
Shares Held
170K
Call Options Held
0
Put Options Held
0
View Full List

About Provention Bio, Inc.

PRVB Quotes by TradingView
  • Ticker PRVB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 81,549,904
  • Description
  • Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...
More about PRVB
Track This Portfolio

Track Fora Capital, LLC Portfolio

Follow Fora Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fora Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email